Lower virus neutralizing titers against SARS-CoV-2 Omicron strain after third dose BNT162b2 following primo-vaccination with ChAdOx1 versus BNT162b2 in cancer patients

Debie, Y.; Van Audenaerde, J.; Vandamme, T.; Croes, L.; Teuwen, L. A. M. N.; Verbruggen, L.; Vanhoutte, G.; Marcq, E.; Le Blon, D.; Peeters, B.; Goossens, M. E.; Arien, K.; Anguille, S.; Smits, E.; Vulsteke, C.; Lion, E.; Peeters, M.; van Dam, P. A.

Debie, Y.; Van Audenaerde, J.; Vandamme, T.; Croes, L.; Teuwen, L. A. M. N.; Verbruggen, L.; Vanhoutte, G.; Marcq, E.; Le Blon, D.; Peeters, B.; Goossens, M. E.; Arien, K.; Anguille, S.; Smits, E.; Vulsteke, C.; Lion, E.; Peeters, M.; van Dam, P. A..

Annals of Oncology ; 33:S1305-S1305, 2022.

Article in English | Academic Search Complete | ID: covidwho-2027894

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: Academic Search Complete Topics: Vaccines / Variants Language: English Journal: Annals of Oncology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google